IP Library Granted Patent US 7,521,055
Granted Patent B2
US 7,521,055 · App. 11/641,589 · Granted Apr 21, 2009

Ferroportin1 antibodies and methods

Assignee: Children's Medical Center Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,521,055
App. No.
11/641,589
Granted
Apr 21, 2009
Kind
B2
Abstract

Positional cloning has been carried out to identify the gene responsible for the hypochromic anemia of the zebrafish mutant weissherbst. The gene, ferroportin1, encodes a novel multiple-transmembrane domain protein, expressed in the yolk sac. Zebrafish ferroportin1 is required for the transport of iron from maternally-derived yolk stores to the circulation, and functions as an iron exporter when expressed in Xenopus oocytes. Human and mouse homologs of the ferroportin1 gene have been identified. The invention includes isolated polynucleotides, vectors and host cells comprising nucleotide sequences encoding Ferroportin1 proteins and variants thereof, including those having iron transport function. The invention also includes polypeptides encoded by ferroportin1 genes and variants of such polypeptides, and fusion polypeptides comprising a Ferroportin1 or a portion thereof. Methods to produce a Ferroportin1, methods to produce antibodies to a Ferroportin1 and methods to identify agents binding to a Ferroportin1, which can be inhibitors or enhancers of Ferroportin1 iron transport activity, are also described. Inhibitors of Ferroportin1 activity can be used in a therapy for hemochromatosis.

Claims (7)

1. A method for eliciting an immune response in an animal, said method comprising introducing into the animal a composition comprising a polypeptide comprising at least 19 consecutive amino acid residues of SEQ ID NO:2.

2. A method for eliciting an immune response in an animal, said method comprising introducing into the animal a composition comprising a polypeptide comprising at least 19 consecutive amino acid residues of SEQ ID NO:4.

3. A method for eliciting an immune response in an animal, said method comprising introducing into the animal a composition comprising a polypeptide comprising at least 19 consecutive amino acid residues of SEQ ID NO:6.

4. An antibody that binds specifically to at least one Ferroportin1 protein, wherein the amino acid sequence of the protein consists of SEQ ID NO:2, SEQ ID NO:4 or SEQ ID NO:6.

5. A method for producing antibodies, said method comprising introducing into an animal isolated zebrafish Ferroportin1 protein, wherein the amino acid sequence of the protein consists of SEQ ID NO:2, or introducing into an animal an antigenic fragment of the zebrafish Ferroportin1 protein.

6. A method for producing antibodies, said method comprising introducing into a non-murine animal isolated mouse Ferroportin1 protein, wherein the amino acid sequence of the protein consists of SEQ ID NO:4, or introducing into a non-murine animal an antigenic fragment of the mouse Ferroportin1 protein.

7. A method for producing antibodies, said method comprising introducing into a non-human animal isolated human Ferroportin1 protein, wherein the amino acid sequence of the protein consists of SEQ ID NO:6, or introducing into a non-human animal an antigenic fragment of the human Ferroportin1 protein.

Assignments (1)
CONFIRMATORY LICENSE Recorded Feb 23, 2021
From: BOSTON CHILDREN'S HOSPITAL
To: NIH-DEITR
Reel/Frame 055373/0068 →
Continuity (4)
Division 0971592700 · Nov 17, 2000
Continuation In Part 0956767200 · May 9, 2000
Provisional Application 6013338200 · May 10, 1999
Related Publication 20070218055A1 · Sep 20, 2007